TIR Signalling Pathway Pharmacogenomics and Opioid Response: beyond the mu opioid receptor

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1011521

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This project will identify why some people respond poorly and others have toxic side effects to the major group of pain relieving medications, the opioids. The basis will be the genetics of the immune system and both acute postoperative and chronic cancer pain patients will be studied in this international pharmacogenetics project.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2013

Funding Scheme: Project Grants

Funding Amount: $246,396.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Pharmacogenomics

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

acute pain | adverse effects | cancer pain | opioid analgesia | pharmacogenetics | pharmacogenomics | side-effects | symptom reduction | treatment efficacy

Related Links